MIMPARA Side Effects

7021439-4 | Blood Creatinine Increased, Blood Parathyroid Hormone Increased, Calciphylaxis, Complications Of Transplanted Kidney, Parathyroidectomy, Renal Failure
on Sep 21, 2010 Female patient from SWEDEN , weighting 173.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood parathyroid hormone increased, calciphylaxis, complications of transplanted kidney, parathyroidectomy, renal failure. Mimpara dosage: . During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PREDNISOLON (View Prednisolon Review and Prednisolon Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), PLENDIL (View Plendil Review and Plendil Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ). Patient was hospitalized.

7016896-3 | Dyspnoea, Pleural Effusion
Patient was taking Mimpara (View Usage). Patient had the following side effects: dyspnoea, pleural effusion on Sep 17, 2010 from GREECE Additional patient health information: Female patient , 69 years of age, was diagnosed with hyperparathyroidism primary and. Mimpara dosage: . Patient was hospitalized.

6646760-0 | Somnolence, Transaminases Increased
Adverse event was reported on Mar 15, 2010 by a Female patient taking Mimpara (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary, pain (What is pain?) and. Location: GERMANY , 70 years of age, After Mimpara was administered, patient had the following side effects: somnolence, transaminases increased. During the same period patient was treated with FENTANYL (View Fentanyl Review and Fentanyl Label ), DREISAVIT (View Dreisavit Review and Dreisavit Label ), FOSRENOL (View Fosrenol Review and Fosrenol Label ), DIGITOXIN INJ (View Digitoxin Inj Review and Digitoxin Inj Label ), MCP RATIOPHARM (View Mcp-ratiopharm Review and Mcp-ratiopharm Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), METAMIZOLE (View Metamizole Review and Metamizole Label ), BENSERAZIDE HYDROCHLORIDE/LEVODOPA (View Benserazide Hydrochloride/levodopa Review and Benserazide Hydrochloride/levodopa Label ). Patient was hospitalized.

6628930-0 | Myocardial Infarction
on Mar 04, 2010 Female patient from UNITED KINGDOM , 44 years of age, was treated with Mimpara (View Usage). Patient experienced the following unwanted or unexpected effects: myocardial infarction. Mimpara dosage: .


6621537-0 | Cogwheel Rigidity, Extrapyramidal Disorder, Tremor
on Mar 02, 2010 Female patient from FRANCE , weighting 112.4 lb, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara (View Usage). Patient had the following side effects: cogwheel rigidity, extrapyramidal disorder, tremor. Mimpara dosage: . During the same period patient was treated with REQUIP (View Requip Review and Requip Label ).

6577754-1 | Somnolence, Transaminases Increased
Patient was taking Mimpara (View Usage). After Mimpara was administered, patient had the following side effects: somnolence, transaminases increased on Feb 01, 2010 from GERMANY Additional patient health information: Female patient , 70 years of age, was diagnosed with hyperparathyroidism secondary, pain (What is pain?) and. Mimpara dosage: . During the same period patient was treated with FENTANYL 100 (View Fentanyl-100 Review and Fentanyl-100 Label ), DREISAVIT (View Dreisavit Review and Dreisavit Label ), FOSRENOL (View Fosrenol Review and Fosrenol Label ), DIGITOXIN (View Digitoxin Review and Digitoxin Label ), MCP RATIOPHARM (View Mcp-ratiopharm Review and Mcp-ratiopharm Label ), ACETYLSALICYLIC ACID (View Acetylsalicylic Acid Review and Acetylsalicylic Acid Label ), METAMIZOLE (View Metamizole Review and Metamizole Label ), BENSERAZIDE HYDROCHLORIDE/LEVODOPA (View Benserazide Hydrochloride/levodopa Review and Benserazide Hydrochloride/levodopa Label ). Patient was hospitalized.

6572502-3 | Blood Creatinine Increased, Blood Parathyroid Hormone Increased, Calciphylaxis, Complications Of Transplanted Kidney, Parathyroidectomy, Renal Failure
Adverse event was reported on Jan 29, 2010 by a Female patient taking Mimpara (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary and. Location: SWEDEN , weighting 173.3 lb, Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood parathyroid hormone increased, calciphylaxis, complications of transplanted kidney, parathyroidectomy, renal failure. During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PREDNISOLON (View Prednisolon Review and Prednisolon Label ), CITALOPRAM (View Citalopram Review and Citalopram Label ), PLENDIL (View Plendil Review and Plendil Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ). Patient was hospitalized.

6546573-4 | Arthralgia, Bone Pain, Cardiomegaly, Disease Complication, Gait Disturbance, High Turnover Osteopathy, Muscular Weakness, Refractory Anaemia
on Jan 15, 2010 Male patient from GERMANY , weighting 125.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara (View Usage). Patient had the following side effects: arthralgia, bone pain, cardiomegaly, disease complication, gait disturbance, high turnover osteopathy, muscular weakness, refractory anaemia. Mimpara dosage: . During the same period patient was treated with FENISTIL (View Fenistil Review and Fenistil Label ), RENAGEL (View Renagel Review and Renagel Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), SODIUM BICARBONATE (View Sodium Bicarbonate Review and Sodium Bicarbonate Label ), CALCIUM ACETATE (View Calcium Acetate Review and Calcium Acetate Label ), NEXIUM (View Nexium Review and Nexium Label ), FOSRENOL (View Fosrenol Review and Fosrenol Label ), DEKRISTOL (View Dekristol Review and Dekristol Label ).

6538076-8 | Blood Pressure Increased, Depressed Level Of Consciousness, Haemorrhage Intracranial, Vomiting
on Jan 11, 2010 Male patient from UNITED KINGDOM , weighting 33.07 lb, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara (View Usage). After Mimpara was administered, patient had the following side effects: blood pressure increased, depressed level of consciousness, haemorrhage intracranial, vomiting. Mimpara dosage: . During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), IRON (View Iron Review and Iron Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), EPOGEN (View Epogen Review and Epogen Label ). Patient was hospitalized.

6535315-4 | Blood Pressure Increased, Depressed Level Of Consciousness, Haemorrhage Intracranial, Vomiting
Patient was taking Mimpara (View Usage). Patient experienced the following unwanted or unexpected effects: blood pressure increased, depressed level of consciousness, haemorrhage intracranial, vomiting on Jan 05, 2010 from UNITED KINGDOM Additional patient health information: Male patient , weighting 33.07 lb, was diagnosed with hyperparathyroidism secondary and. Mimpara dosage: . During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), IRON (View Iron Review and Iron Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), EPOGEN (View Epogen Review and Epogen Label ). Patient was hospitalized.

6528837-3 | Blood Pressure Increased, Depressed Level Of Consciousness, Haemorrhage Intracranial, Vomiting
Adverse event was reported on Mar 05, 2009 by a Male patient taking Mimpara (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary and. Location: UNITED KINGDOM , weighting 33.07 lb, Patient had the following side effects: blood pressure increased, depressed level of consciousness, haemorrhage intracranial, vomiting. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), DOMPERIDONE (View Domperidone Review and Domperidone Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), LACTULOSE (View Lactulose Review and Lactulose Label ), ALFACALCIDOL (View Alfacalcidol Review and Alfacalcidol Label ), IRON (View Iron Review and Iron Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), EPOGEN (View Epogen Review and Epogen Label ). Patient was hospitalized.

6481003-2 | Myalgia, Nausea
on Dec 01, 2009 Male patient from GERMANY , weighting 172.0 lb, was treated with Mimpara (View Usage). After Mimpara was administered, patient had the following side effects: myalgia, nausea (What is nausea?). Mimpara dosage: . During the same period patient was treated with METOHEXAL (View Metohexal Review and Metohexal Label ), NEXIUM (View Nexium Review and Nexium Label ), FUROSEMID (View Furosemid Review and Furosemid Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), VITAMIN D3 (View Vitamin D3 Review and Vitamin D3 Label ), FOSRENOL (View Fosrenol Review and Fosrenol Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ).

6481002-0 | Blood Creatinine Increased, Blood Parathyroid Hormone Increased, Calciphylaxis, Complications Of Transplanted Kidney, Renal Failure
on Dec 01, 2009 Female patient from SWEDEN , weighting 173.3 lb, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara (View Usage). Patient experienced the following unwanted or unexpected effects: blood creatinine increased, blood parathyroid hormone increased, calciphylaxis, complications of transplanted kidney, renal failure. Mimpara dosage: . During the same period patient was treated with PROGRAF (View Prograf Review and Prograf Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), PREDNISOLONE (View Prednisolone Review and Prednisolone Label ), CITALOPRAM HYDROBROMIDE (View Citalopram Hydrobromide Review and Citalopram Hydrobromide Label ), PLENDIL (View Plendil Review and Plendil Label ), SODIUM BICARBONATE IN PLASTIC CONTAINER (View Sodium Bicarbonate In Plastic Container Review and Sodium Bicarbonate In Plastic Container Label ).

6442861-0 | Anaemia, Disease Complication, High Turnover Osteopathy
Patient was taking Mimpara (View Usage). Patient had the following side effects: anaemia, disease complication, high turnover osteopathy on Nov 09, 2009 from GERMANY Additional patient health information: Male patient , weighting 125.7 lb, was diagnosed with hyperparathyroidism secondary and. Mimpara dosage: . During the same period patient was treated with FENISTIL (View Fenistil Review and Fenistil Label ), RENAGEL (View Renagel Review and Renagel Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), SODIUM BICARBONATE IN PLASTIC CONTAINER (View Sodium Bicarbonate In Plastic Container Review and Sodium Bicarbonate In Plastic Container Label ), CALCIUM ACETATE (View Calcium Acetate Review and Calcium Acetate Label ), NEXIUM (View Nexium Review and Nexium Label ), FOSRENOL (View Fosrenol Review and Fosrenol Label ), DEKRISTOL (View Dekristol Review and Dekristol Label ).

6438394-8 | Bone Pain, Myalgia, Nausea
Adverse event was reported on Nov 06, 2009 by a Male patient taking Mimpara (View Usage) (Dosage: ) . Location: GERMANY , weighting 172.0 lb, After Mimpara was administered, patient had the following side effects: bone pain, myalgia, nausea (What is nausea?). During the same period patient was treated with METOHEXAL (View Metohexal Review and Metohexal Label ), NEXIUM (View Nexium Review and Nexium Label ), FUROSEMID (View Furosemid Review and Furosemid Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), FERROUS SULFATE TAB (View Ferrous Sulfate Tab Review and Ferrous Sulfate Tab Label ), VITAMIN D3 (View Vitamin D3 Review and Vitamin D3 Label ), FOSRENOL (View Fosrenol Review and Fosrenol Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ).

6426358-X | Asthenia, Benign Bone Neoplasm, Bone Disorder, Gait Disturbance, High Turnover Osteopathy, Myalgia, Osteoarthritis, Osteosclerosis, Pain In Extremity
on Oct 27, 2009 Female patient from GERMANY , weighting 143.3 lb, was diagnosed with hyperparathyroidism primary and was treated with Mimpara (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, benign bone neoplasm, bone disorder, gait disturbance, high turnover osteopathy, myalgia, osteoarthritis (What is osteoarthritis?), osteosclerosis, pain in extremity. Mimpara dosage: . During the same period patient was treated with NOVODIGAL (View Novodigal Review and Novodigal Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), THYRONAJOD (View Thyronajod Review and Thyronajod Label ).

6422343-2 | Blood Parathyroid Hormone Increased, Hypercalcaemia
on Oct 23, 2009 Male patient from GERMANY , 52 years of age, weighting 169.8 lb, was diagnosed with hyperparathyroidism primary and was treated with Mimpara (View Usage). Patient had the following side effects: blood parathyroid hormone increased, hypercalcaemia. Mimpara dosage: . During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ). Patient was hospitalized.

6410936-8 | Abdominal Pain Upper, Acute Myocardial Infarction, Leukocytoclastic Vasculitis, Purpura
Patient was taking Mimpara (View Usage). After Mimpara was administered, patient had the following side effects: abdominal pain upper, acute myocardial infarction, leukocytoclastic vasculitis, purpura on Oct 16, 2009 from GREECE Additional patient health information: Female patient , 81 years of age, weighting 125.7 lb, was diagnosed with hyperparathyroidism secondary and. Mimpara dosage: . During the same period patient was treated with PARICALCITOL (View Paricalcitol Review and Paricalcitol Label ), SEVELAMER (View Sevelamer Review and Sevelamer Label ), ARANESP (View Aranesp Review and Aranesp Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

6406045-4 | Asthenia, Bone Disorder, Decreased Appetite, Gait Disturbance, High Turnover Osteopathy, Myalgia, Osteoarthritis, Pain In Extremity
Adverse event was reported on Oct 09, 2009 by a Female patient taking Mimpara (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism primary and. Location: GERMANY , weighting 143.3 lb, Patient experienced the following unwanted or unexpected effects: asthenia, bone disorder, decreased appetite, gait disturbance, high turnover osteopathy, myalgia, osteoarthritis (What is osteoarthritis?), pain in extremity. During the same period patient was treated with NOVODIGAL (View Novodigal Review and Novodigal Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), THYRONAJOD (View Thyronajod Review and Thyronajod Label ).

6399400-2 | Aortic Stenosis, Calciphylaxis, Diarrhoea, Gastrointestinal Viral Infection, Hypertensive Crisis, Nausea, Transaminases Increased
on Oct 07, 2009 Female patient from GERMANY , weighting 127.9 lb, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara (View Usage). Patient had the following side effects: aortic stenosis, calciphylaxis, diarrhoea, gastrointestinal viral infection, hypertensive crisis, nausea (What is nausea?), transaminases increased. Mimpara dosage: . During the same period patient was treated with SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), PARICALCITOL (View Paricalcitol Review and Paricalcitol Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), RENAGEL (View Renagel Review and Renagel Label ).

6395709-7 | Blood Parathyroid Hormone Increased, Hypercalcaemia
on Oct 05, 2009 Male patient from GERMANY , 52 years of age, weighting 169.8 lb, was diagnosed with hyperparathyroidism primary and was treated with Mimpara (View Usage). After Mimpara was administered, patient had the following side effects: blood parathyroid hormone increased, hypercalcaemia. Mimpara dosage: . During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ). Patient was hospitalized.

6368137-8 | Hypocalcaemia, Metabolic Acidosis, Muscular Weakness, Myalgia, Nausea, Oesophagitis Ulcerative, Paraesthesia, Pneumonia
Patient was taking Mimpara (View Usage). Patient experienced the following unwanted or unexpected effects: hypocalcaemia, metabolic acidosis, muscular weakness, myalgia, nausea (What is nausea?), oesophagitis ulcerative, paraesthesia, pneumonia (What is pneumonia?) on Sep 11, 2009 from FRANCE Additional patient health information: Female patient , 57 years of age, was diagnosed with hyperparathyroidism primary and. Mimpara dosage: . During the same period patient was treated with DICLOFENAC (View Diclofenac Review and Diclofenac Label ), DEPAKENE (View Depakene Review and Depakene Label ), GARDENAL (View Gardenal Review and Gardenal Label ), EPOGEN (View Epogen Review and Epogen Label ), CALCIUM CHLORIDE DIHYDRATE (View Calcium Chloride Dihydrate Review and Calcium Chloride Dihydrate Label ). Patient was hospitalized.

6367819-1 | Abdominal Pain Upper, Acute Myocardial Infarction, Leukocytoclastic Vasculitis, Purpura
Adverse event was reported on Sep 17, 2009 by a Female patient taking Mimpara (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary and. Location: GREECE , 80 years of age, Patient had the following side effects: abdominal pain upper, acute myocardial infarction, leukocytoclastic vasculitis, purpura. During the same period patient was treated with PARICALCITOL (View Paricalcitol Review and Paricalcitol Label ), SEVELAMER (View Sevelamer Review and Sevelamer Label ), ERYTHROPOIETIN HUMAN (View Erythropoietin Human Review and Erythropoietin Human Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

6358390-9 | Abdominal Pain Upper, Acute Myocardial Infarction, Leukocytoclastic Vasculitis, Purpura
on Sep 10, 2009 Female patient from GREECE , 80 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara (View Usage). After Mimpara was administered, patient had the following side effects: abdominal pain upper, acute myocardial infarction, leukocytoclastic vasculitis, purpura. Mimpara dosage: . During the same period patient was treated with PARICALCITOL (View Paricalcitol Review and Paricalcitol Label ), SEVELAMER (View Sevelamer Review and Sevelamer Label ), ERYTHROPOIETIN HUMAN (View Erythropoietin Human Review and Erythropoietin Human Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

6349040-6 | Hypocalcaemia, Metabolic Acidosis, Muscular Weakness, Nausea, Paraesthesia, Renal Failure Acute
on Sep 07, 2009 Female patient from FRANCE , 57 years of age, was diagnosed with hyperparathyroidism primary and was treated with Mimpara (View Usage). Patient experienced the following unwanted or unexpected effects: hypocalcaemia, metabolic acidosis, muscular weakness, nausea (What is nausea?), paraesthesia, renal failure acute. Mimpara dosage: . During the same period patient was treated with DICLOFENAC SODIUM (View Diclofenac Sodium Review and Diclofenac Sodium Label ), DEPAKENE (View Depakene Review and Depakene Label ), GARDENAL (View Gardenal Review and Gardenal Label ). Patient was hospitalized.

6332521-9 | Asthenia, Benign Bone Neoplasm, Bone Disorder, Decreased Appetite, Gait Disturbance, High Turnover Osteopathy, Myalgia, Pain In Extremity
Patient was taking Mimpara (View Usage). Patient had the following side effects: asthenia, benign bone neoplasm, bone disorder, decreased appetite, gait disturbance, high turnover osteopathy, myalgia, pain in extremity on Aug 18, 2009 from GERMANY Additional patient health information: Female patient , weighting 143.3 lb, was diagnosed with hyperparathyroidism primary and. Mimpara dosage: . During the same period patient was treated with NOVODIGAL (View Novodigal Review and Novodigal Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), SPIRONOLACTONE (View Spironolactone Review and Spironolactone Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), THYRONAJOD (View Thyronajod Review and Thyronajod Label ).

6305381-X | Convulsion, Muscle Spasms
Adverse event was reported on Aug 03, 2009 by a Male patient taking Mimpara (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary and. Location: UNITED KINGDOM , 84 years of age, weighting 141.1 lb, After Mimpara was administered, patient had the following side effects: convulsion, muscle spasms. During the same period patient was treated with CARBAMAZEPINE (View Carbamazepine Review and Carbamazepine Label ), EPREX (View Eprex Review and Eprex Label ), TINZAPARIN SODIUM (View Tinzaparin Sodium Review and Tinzaparin Sodium Label ), VENOFER (View Venofer Review and Venofer Label ).

6305374-2 | Asthenia, Bone Neoplasm, Decreased Appetite, High Turnover Osteopathy, Myalgia
on Aug 05, 2009 Female patient from GERMANY , 91 years of age, was diagnosed with hyperparathyroidism primary and was treated with Mimpara (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, bone neoplasm, decreased appetite, high turnover osteopathy, myalgia. Mimpara dosage: .

6303709-8 | Abdominal Pain Upper, Acute Myocardial Infarction, Leukocytoclastic Vasculitis, Purpura
on Jul 31, 2009 Female patient from GREECE , 80 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara (View Usage). Patient had the following side effects: abdominal pain upper, acute myocardial infarction, leukocytoclastic vasculitis, purpura. Mimpara dosage: . During the same period patient was treated with PARICALCITOL (View Paricalcitol Review and Paricalcitol Label ), SEVELAMER (View Sevelamer Review and Sevelamer Label ), ERYTHROPOIETIN HUMAN (View Erythropoietin Human Review and Erythropoietin Human Label ), PRAVASTATIN (View Pravastatin Review and Pravastatin Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), BROMAZEPAM (View Bromazepam Review and Bromazepam Label ), HYDROXYZINE (View Hydroxyzine Review and Hydroxyzine Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ). Patient was hospitalized.

6299304-X | Aortic Stenosis, Calciphylaxis, Diarrhoea, Gastrointestinal Viral Infection, Hypertensive Crisis, Nausea, Transaminases Increased
Patient was taking Mimpara (View Usage). After Mimpara was administered, patient had the following side effects: aortic stenosis, calciphylaxis, diarrhoea, gastrointestinal viral infection, hypertensive crisis, nausea (What is nausea?), transaminases increased on Jul 31, 2009 from GERMANY Additional patient health information: Female patient , weighting 127.9 lb, was diagnosed with hyperparathyroidism secondary and. Mimpara dosage: . During the same period patient was treated with PARICALCITOL (View Paricalcitol Review and Paricalcitol Label ), TORSEMIDE (View Torsemide Review and Torsemide Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), RENAGEL (View Renagel Review and Renagel Label ).

6287443-9 | Arteriovenous Fistula Occlusion, Cardiac Arrest, Cardiogenic Shock, Cerebrovascular Accident, Diarrhoea, Myocardial Infarction
Adverse event was reported on Jul 20, 2009 by a Male patient taking Mimpara (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary and. Location: GERMANY , weighting 167.6 lb, Patient experienced the following unwanted or unexpected effects: arteriovenous fistula occlusion, cardiac arrest (What is cardiac arrest?), cardiogenic shock, cerebrovascular accident, diarrhoea, myocardial infarction. During the same period patient was treated with VITARENAL (View Vitarenal Review and Vitarenal Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), INSUMAN (View Insuman Review and Insuman Label ), ACTRAPID INSULIN NOVO (View Actrapid Insulin Novo Review and Actrapid Insulin Novo Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ). Patient was hospitalized.

6286052-5 | Muscle Spasms, Musculoskeletal Pain, Tonic Clonic Movements
on Jul 20, 2009 Male patient from AUSTRIA , 47 years of age, weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara (View Usage). Patient had the following side effects: muscle spasms, musculoskeletal pain, tonic clonic movements. Mimpara dosage: . During the same period patient was treated with RENAGEL (View Renagel Review and Renagel Label ), ETALPHA (View Etalpha Review and Etalpha Label ), THYREX (View Thyrex Review and Thyrex Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ).

6273214-6 | Diarrhoea, Diverticulum
on Jul 13, 2009 Female patient from GERMANY , weighting 173.1 lb, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara (View Usage). After Mimpara was administered, patient had the following side effects: diarrhoea, diverticulum. Mimpara dosage: . During the same period patient was treated with VITARENAL (View Vitarenal Review and Vitarenal Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LEVODOPA (View Levodopa Review and Levodopa Label ), BISOPROLOL FUMARATE (View Bisoprolol Fumarate Review and Bisoprolol Fumarate Label ), CALCIUM ACETATE (View Calcium Acetate Review and Calcium Acetate Label ).

6271352-5 | Cardiogenic Shock, Cerebrovascular Accident, Diarrhoea, Myocardial Infarction
Patient was taking Mimpara (View Usage). Patient experienced the following unwanted or unexpected effects: cardiogenic shock, cerebrovascular accident, diarrhoea, myocardial infarction on Jul 13, 2009 from GERMANY Additional patient health information: Male patient , weighting 167.6 lb, was diagnosed with hyperparathyroidism secondary and. Mimpara dosage: . During the same period patient was treated with VITARENAL (View Vitarenal Review and Vitarenal Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), INSUMAN (View Insuman Review and Insuman Label ), ACTRAPID INSULIN NOVO (View Actrapid Insulin Novo Review and Actrapid Insulin Novo Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ). Patient was hospitalized.

6270722-9 | Abdominal Pain, Nausea
Adverse event was reported on Jul 10, 2009 by a Male patient taking Mimpara (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary and. Location: GERMANY , weighting 147.7 lb, Patient had the following side effects: abdominal pain (What is abdominal pain?), nausea (What is nausea?). During the same period patient was treated with METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), DELIX (View Delix Review and Delix Label ). Patient was hospitalized.

6265538-3 | Diarrhoea, Gastrointestinal Viral Infection, Hepatic Lesion, Nausea, Transaminases Increased
on Jul 02, 2009 Female patient from GERMANY , weighting 127.9 lb, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara (View Usage). After Mimpara was administered, patient had the following side effects: diarrhoea, gastrointestinal viral infection, hepatic lesion, nausea (What is nausea?), transaminases increased. Mimpara dosage: . During the same period patient was treated with PARICALCITOL (View Paricalcitol Review and Paricalcitol Label ), TORASEMIDE (View Torasemide Review and Torasemide Label ), ENALAPRIL (View Enalapril Review and Enalapril Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), GABAPENTIN (View Gabapentin Review and Gabapentin Label ), RENAGEL (View Renagel Review and Renagel Label ).

6262693-6 | Dyspnoea, Hypersensitivity, Localised Oedema
on Jul 03, 2009 Female patient from SWITZERLAND , 61 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara (View Usage). Patient experienced the following unwanted or unexpected effects: dyspnoea, hypersensitivity, localised oedema. Mimpara dosage: . During the same period patient was treated with KALETRA (View Kaletra Review and Kaletra Label ), INVIRASE (View Invirase Review and Invirase Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), AVELOX (View Avelox Review and Avelox Label ), RECORMON (View Recormon Review and Recormon Label ), VENOFER (View Venofer Review and Venofer Label ), ROCALTROL (View Rocaltrol Review and Rocaltrol Label ).

6252778-2 | Blood Parathyroid Hormone Increased, Convulsion
Patient was taking Mimpara (View Usage). Patient had the following side effects: blood parathyroid hormone increased, convulsion on Jun 23, 2009 from AUSTRIA Additional patient health information: Male patient , 77 years of age, weighting 158.7 lb, was diagnosed with hyperparathyroidism primary and. Mimpara dosage: . During the same period patient was treated with ACECOMB (View Acecomb Review and Acecomb Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), PARIET (View Pariet Review and Pariet Label ).

6245598-6 | Cerebrovascular Accident, Hypoaesthesia, Pruritus
Adverse event was reported on Jun 22, 2009 by a Female patient taking Mimpara (View Usage) (Dosage: ) . Location: SPAIN , 47 years of age, After Mimpara was administered, patient had the following side effects: cerebrovascular accident, hypoaesthesia, pruritus. During the same period patient was treated with ACFOL (View Acfol Review and Acfol Label ), PYRIDOXINE (View Pyridoxine Review and Pyridoxine Label ), THIAMINE HCL (View Thiamine Hcl Review and Thiamine Hcl Label ), FUROSEMIDE INTENSOL (View Furosemide Intensol Review and Furosemide Intensol Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), SEVELAMER (View Sevelamer Review and Sevelamer Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ). Patient was hospitalized.

6241267-7 | Abdominal Pain, Nausea, Peritonitis Bacterial
on Jun 16, 2009 Male patient from GERMANY , weighting 147.7 lb, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara (View Usage). Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), nausea (What is nausea?), peritonitis bacterial. Mimpara dosage: . During the same period patient was treated with METOPROLOL TARTRATE (View Metoprolol Tartrate Review and Metoprolol Tartrate Label ), DELIX (View Delix Review and Delix Label ). Patient was hospitalized.

6236324-5 | Renal Impairment
on Jun 12, 2009 Male patient from SPAIN , weighting 176.8 lb, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara (View Usage). Patient had the following side effects: renal impairment. Mimpara dosage: . During the same period patient was treated with SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), IMUREL (View Imurel Review and Imurel Label ), VERAPAMIL HYDROCHLORIDE (View Verapamil Hydrochloride Review and Verapamil Hydrochloride Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ROCALTROL (View Rocaltrol Review and Rocaltrol Label ), CARDYL (View Cardyl Review and Cardyl Label ), ENALAPRIL MALEATE (View Enalapril Maleate Review and Enalapril Maleate Label ).

6236321-X | Blood Pressure Decreased, Chest Discomfort, Pruritus
Patient was taking Mimpara (View Usage). After Mimpara was administered, patient had the following side effects: blood pressure decreased, chest discomfort, pruritus on Jun 11, 2009 from FRANCE Additional patient health information: Male patient , weighting 126.8 lb, was diagnosed with anaemia and. Mimpara dosage: . During the same period patient was treated with MICERA (View Micera Review and Micera Label ), VENOFER (View Venofer Review and Venofer Label ), LASIX (View Lasix Review and Lasix Label ), RENAGEL (View Renagel Review and Renagel Label ), SPECIAFOLDINE (View Speciafoldine Review and Speciafoldine Label ), ZYLORIC (View Zyloric Review and Zyloric Label ), VITAMIN B 12 (View Vitamin B-12 Review and Vitamin B-12 Label ), DUPHALAC (View Duphalac Review and Duphalac Label ).

6233279-4 | Cardiogenic Shock, Cerebrovascular Accident, Diarrhoea, Myocardial Infarction
Adverse event was reported on Jun 10, 2009 by a Male patient taking Mimpara (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary and. Location: GERMANY , weighting 167.6 lb, Patient experienced the following unwanted or unexpected effects: cardiogenic shock, cerebrovascular accident, diarrhoea, myocardial infarction. During the same period patient was treated with VITARENAL (View Vitarenal Review and Vitarenal Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), INSUMAN (View Insuman Review and Insuman Label ), ACTRAPID INSULIN NOVO (View Actrapid Insulin Novo Review and Actrapid Insulin Novo Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ). Patient was hospitalized.

6231870-2 | Dyspnoea, Hypersensitivity, Localised Oedema
on Jun 08, 2009 Female patient from SWITZERLAND , 61 years of age, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara (View Usage). Patient had the following side effects: dyspnoea, hypersensitivity, localised oedema. Mimpara dosage: . During the same period patient was treated with KALETRA (View Kaletra Review and Kaletra Label ), INVIRASE (View Invirase Review and Invirase Label ), LAMIVUDINE (View Lamivudine Review and Lamivudine Label ), AVELOX (View Avelox Review and Avelox Label ), RECORMON (View Recormon Review and Recormon Label ), VENOFER (View Venofer Review and Venofer Label ), ROCALTROL (View Rocaltrol Review and Rocaltrol Label ).

6231271-7 | Cardiac Disorder, Cerebrovascular Accident, Hypoaesthesia, Pruritus
on Jun 10, 2009 Female patient from SPAIN , 47 years of age, was treated with Mimpara (View Usage). After Mimpara was administered, patient had the following side effects: cardiac disorder, cerebrovascular accident, hypoaesthesia, pruritus. Mimpara dosage: . During the same period patient was treated with ACFOL (View Acfol Review and Acfol Label ), PYRIDOXINE (View Pyridoxine Review and Pyridoxine Label ), THIAMINE HCL (View Thiamine Hcl Review and Thiamine Hcl Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), SEVELAMER (View Sevelamer Review and Sevelamer Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ). Patient was hospitalized.

6229864-6 | Eosinophilia, Face Oedema, Pruritus, Rash Maculo-papular
Patient was taking Mimpara (View Usage). Patient experienced the following unwanted or unexpected effects: eosinophilia, face oedema, pruritus, rash maculo-papular on Jun 03, 2009 from FRANCE Additional patient health information: Male patient , 58 years of age, was diagnosed with hyperparathyroidism secondary and. Mimpara dosage: . During the same period patient was treated with CORTICOSTEROID NOS (View Corticosteroid Nos Review and Corticosteroid Nos Label ). Patient was hospitalized.

6223309-8 | Diarrhoea, Diverticulum
Adverse event was reported on Jun 05, 2009 by a Female patient taking Mimpara (View Usage) (Dosage: ) was diagnosed with hyperparathyroidism secondary and. Location: GERMANY , weighting 173.1 lb, Patient had the following side effects: diarrhoea, diverticulum. During the same period patient was treated with VITARENAL (View Vitarenal Review and Vitarenal Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), LEVODOPA (View Levodopa Review and Levodopa Label ), BISOPROLOL (View Bisoprolol Review and Bisoprolol Label ), CALCIUM ACETATE (View Calcium Acetate Review and Calcium Acetate Label ).

6217825-2 | Cerebrovascular Accident, Diarrhoea
on May 27, 2009 Male patient from GERMANY , weighting 167.6 lb, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara (View Usage). After Mimpara was administered, patient had the following side effects: cerebrovascular accident, diarrhoea. Mimpara dosage: . During the same period patient was treated with VITARENAL (View Vitarenal Review and Vitarenal Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), INSUMAN (View Insuman Review and Insuman Label ), ACTRAPID INSULIN NOVO (View Actrapid Insulin Novo Review and Actrapid Insulin Novo Label ), MARCUMAR (View Marcumar Review and Marcumar Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ).

6215814-5 | Diarrhoea
on May 27, 2009 Male patient from GERMANY , weighting 235.9 lb, was diagnosed with hyperparathyroidism secondary and was treated with Mimpara (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea. Mimpara dosage: . During the same period patient was treated with SAW PALMETTO (View Saw Palmetto Review and Saw Palmetto Label ), SINGULAIR (View Singulair Review and Singulair Label ), ATROVENT (View Atrovent Review and Atrovent Label ), VITARENAL (View Vitarenal Review and Vitarenal Label ), PLAVIX (View Plavix Review and Plavix Label ), NEORECORMON (View Neorecormon Review and Neorecormon Label ).

6210642-9 | Cardiac Disorder, Hypoaesthesia, Pruritus
Patient was taking Mimpara (View Usage). Patient had the following side effects: cardiac disorder, hypoaesthesia, pruritus on May 25, 2009 from SPAIN Additional patient health information: Female patient , 47 years of age, . Mimpara dosage: . During the same period patient was treated with ACFOL (View Acfol Review and Acfol Label ), PYRIDOXINE (View Pyridoxine Review and Pyridoxine Label ), THIAMINE HCL (View Thiamine Hcl Review and Thiamine Hcl Label ), FUROSEMIDE (View Furosemide Review and Furosemide Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), SEVELAMER (View Sevelamer Review and Sevelamer Label ), ATORVASTATIN CALCIUM (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ). Patient was hospitalized.